Company intelligence / Profile preview
Shanghai Bovax Biotechnology Co., Ltd.
Shanghai, Shanghai, Chinabovaxbio.com ↗
- Ownership
- Private
- Employees
- ~80
- Development stage
- Other
01
Overview
The company has multiple HPV vaccines in clinical development. The 9-valent HPV vaccine is in Phase III clinical trials (first of its kind to enter Phase III in China), the 4-valent HPV vaccine has completed Phase III trials, the 15-valent HPV vaccine has been approved for clinical trials, and the recombinant EV71 vaccine is in Phase I clinical stage.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Recombinant protein vaccinesRecombinant protein drugsVirus-Like Particles (VLPs)
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
Beyond the preview
Go deeper on Shanghai Bovax Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Bovax Biotechnology Co., Ltd..